chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine, she went to bed, the chills started and they were severe to the point of shivering.  She was up all night.  Then the joint pain started and felt like somebody had a hold of her neck from the back and squeezing it, and headache.  After about 4 hours during the night she was aching and hurting like her bones were breaking.  She was thinking of calling 9-1-1 as her pulse was faint.   She then started having hands tingling, pins and needles in her hands and was too weak to get out of the bed, and her phone was in another room and could not get up to call anybody.  Her feet were also icy cold.  She was slight nausea, no vomiting.  The pain and chills were her primary concerns.  Today is her first day after actually sleeping.  She was improving yesterday, and last night she was so tired from not getting any sleep the evening before and slept for 12 hours last night.  She did not take anything for the symptoms as she was too weak to get out of bed to take it.  This is what scared her the most.  She was weak and did not go out yesterday, took a nap and made something to eat, and went to bed early and slept well.  She is not completely recovered, but she is staying put until she is back to her normal.
This spontaneous case reported by a consumer, describes the occurrence of myalgia (slight body aches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jun 1, 2021, patient received the 1st  dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 30, 2021, patient received the 2nd dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 30, 2021, patient experienced myalgia (slight body aches). At the time of the report, myalgia (slight body aches): resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information. This case linked to MOD-2021-222958 (patient link).
About a month after first vaccine, started developing fast heart rate, shortness of breath and dizziness. Symptoms have continued to get worse over time. Recently diagnosed with POTS.
Pt called and said that he got flu shot 3 weeks ago. His arm is still weak and pain. When he was moving his arm in certain directions  and lifting something, he felt pain and weak. Also, he went the check out with the doctor. The doctor said that the flu shot caused the pain. The doctor also said that if the injection site was too high, it could caused pain. The patient said that he remembered that the injection site was up high near his shoulder.
Swelling, tenderness at the vaccination site, fever 100.5, headache, slowly resolved after 3 days, elevated blood pressure for about.
I didn't feel good; Disorientated; I ached all over my body; Weakness; I was shaking like crazy; I felt like I was running a fever, and I was 100.3 F; Headache; I still feel foggy; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (I didn't feel good), DISORIENTATION (Disorientated), PAIN (I ached all over my body), ASTHENIA (Weakness) and FEELING ABNORMAL (I still feel foggy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Coronavirus infection.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced MALAISE (I didn't feel good), DISORIENTATION (Disorientated), PAIN (I ached all over my body), ASTHENIA (Weakness), CHILLS (I was shaking like crazy), PYREXIA (I felt like I was running a fever, and I was 100.3 F) and HEADACHE (Headache). In March 2021, the patient experienced FEELING ABNORMAL (I still feel foggy). The patient was treated with ACETYLSALICYLIC ACID at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 13-Mar-2021, PYREXIA (I felt like I was running a fever, and I was 100.3 F) had resolved. At the time of the report, MALAISE (I didn't feel good), PAIN (I ached all over my body), ASTHENIA (Weakness), CHILLS (I was shaking like crazy) and HEADACHE (Headache) had resolved, DISORIENTATION (Disorientated) outcome was unknown and FEELING ABNORMAL (I still feel foggy) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 100.3f (High) 100.3F and 102.3f (High) 102.3F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was high blood pressure medication NOS and cholesterol medication NOS.  On 12-Mar-2021, the patient felt like they were running a fever and they were, 100.3F. After that, they became disorientated, their fever was 102.3F. They felt like they had the coronavirus all over again.  Treatment included acetylsalicylic acid (Aspirin) and ibuprofen (Motrin).
Numbness and pain in left arm 45 mins after injection, headache  Numbness in left arm and hand everyday since injection  Numbness in right arm, hand, foot day after injection and intermittent since then.   Consistent Numbness in right side face, right arm, right leg and right foot on  day 4 after injection , went to emergency department
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concomitant medication were not provided. On 25-SEP-2016, the patient was vaccinated with improperly stored VARIVAX (lot # M024681, expiration date 18-MAY-2018, 0.5 ml, once, subcutaneous). The vaccines was exposed to 28 Fahrenheit degree for 2 hours and 10 minutes. No adverse effects were reported. Data logger was involved. There was no prior excursion. This is one of several reports received from the same reporter. Additional information has been requested.
Nurse administered undiluted dose of Pfizer for ages 5-11, dose #1 to patient. Guardian informed of error post vaccination via phone call. Guardian stated all patients felt "fine" at time of phone call. Guardian advised to monitor injection sites for adverse reaction, and call clinic back if any adverse effects occur. Nurse addressed all questions and concerns.
Left thigh with 12cm red streak beginning at immunization site.  Non-tender to touch, mom states streak subsiding.  No fever, baby irritable.
Rash to scalp, chest and back. Approx 7 vesicles. Low grade fever, chills, joint pain and weakness.
Severe chills, headache, fever, cold sweats, swelling in armpit near injection site
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022; No adverse event; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 23-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  On 04-Jun-2022 the vials were initially stored in the refrigerator.  Vial did not undergone any temperature excursions.  No treatment information was provided.
pt recv vax;pruritic rash day p/ vax;spread over back,shoulders,face,scalp;lasted 10 days;low grade fever;
About a week and a half after the second booster.  I began to feel sick but negative for COVID-19.  I had fever, chills, night sweats and exhaustion.  It lasted for about a week and general weakness and loss of appetite.  Then I noticed that my right eye was 'hopping' around and had trouble reading.  Symptoms also included headache and light sensitivity.  I visited doctor eye doctor and diagnosed with macular pucker.   My eye doctor referred me to a surgeon that confirmed the diagnosis and I will visit again in September.   I was prescribed an eye drop Ketorolac Tromethamine.  The eye surgeon also noticed that my blood pressure was very high and we would not be able to do surgery until my blood pressure lowers.
Feeling itchy on stomach and back; Rash all over chest, neck, stomach and back; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration on the left arm on 30Apr2021 at 11:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the vaccination. The patient did not receive any medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0167) via an unspecified route of administration in the left arm on 09Apr2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 01May2021, within 24 hours of the vaccine, the patient began to feel itchy on her stomach and back. The itchiness proceeded to get worse and she noticed that she had a rash all over her chest, neck, stomach and back. On 04May2021, it was day 4 of the rash and continued itchiness. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. It was unknown if any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt itchy on stomach and back and rash all over chest, neck, stomach and back was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Allergic reaction, cervical strain, acute muscle pain on encounter. Treatment: FLEXERIL10 mg, DELTASONE 60 mg.
pt recv vax 20SEP95 & 13APR97 pt devel chickenpox consisting of 10-12 vesicles, on the face, scalp, legs, chest & back;pt had a fever of 99;pt recovered by 28APR97;
1/6/20 cough, runny nose, chills, difficulty breathing, HA
PT STATES SWELLING AND ITCHING AT INJECTION SITE, PT TAKING BENADRYL AND USING HYDROCORTISON CREAM AND STATES THAT IT IS HELPING
Dizziness; Missed the recommended window between the two doses; Tiredness; Chills; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), DIZZINESS (Dizziness), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the recommended window between the two doses), FATIGUE (Tiredness) and CHILLS (Chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced DIZZINESS (Dizziness), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the recommended window between the two doses), FATIGUE (Tiredness) and CHILLS (Chills). At the time of the report, COVID-19 (COVID-19), DIZZINESS (Dizziness), FATIGUE (Tiredness) and CHILLS (Chills) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the recommended window between the two doses) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Apr-2021, SARS-CoV-2 test: positive (Positive) COVID test positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated that she might Have taken Motrin for the treatment .  Patient was wondering If she waited too long for the second dose and weather or not she should repeat the first dose.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Reporter's email id was added. Start date of COVID 19 was updated.
6/10/2020 12:30 pm Sleep interruption (unusual), irritability 6:30 pm Diarrhea, irritability  6/11/2020 12:30 am Sleep interruption (unusual), screaming, diarrhea, fever of 101.4 degrees 1:00 am Vomiting, fever persists, irritability and screaming 2:30 am More vomiting, fever persists, irritability and screaming 3:30 am Fever decreased 100.0 degrees 4:30 am Fever remains 100.0 degrees 5:30 am Fever decreased to 99.5 degrees 6:30 am Fever increases to 103.4 degrees, irritability, Motrin administered 7:45 am Irritability 12:15 pm Fever of 101.1 degrees
This spontaneous report as received from a nurse via Center refers to a patient of unknown gender, between the age of 13 years and 18 years old. The patient's medical history and concurrent conditions were unknown. On 21-JUL-2015, the patient was vaccinated with an unknown dose of (Oka/Merck) VARIVAX (route was not reported, lot # K026386, expiry date 15-DEC-2016), which underwent temperature excursion of 8.9 degrees Celsius for 1 hour and 28 minutes on 07-JUL-2015. Concomitant medications were unknown. The patient did not experience any adverse events. This is one of several reports received from the same reporter. Additional information has been requested.
Feeling nauseous; Fever; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Feeling nauseous) and PYREXIA (Fever) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced NAUSEA (Feeling nauseous) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, NAUSEA (Feeling nauseous) and PYREXIA (Fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-May-2021, Body temperature: 102 (Inconclusive) Fever of 102 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Left arm pain and burning can not  rotate above head , or lean elbow hard on surfaces . have had several treatments nothing works , had a mri ,  started approx 2 weeks after the booster
the patient was not of age to receive the vaccine, the patient was 4 and needed to be age 5 to receive vaccine
VERY FUSSY, IRRITABLE, TEMP 99.0 F.  TYLENOL SEEMS TO HELP.
First dose was Janssen on  03/31/2021. This is the second dose. Noted Right under arm, pectoral muscle inflammation and pain. Still have some inflammation and pain in the injection spot. Will consult with Doctor if it get worse or other symptoms appear.
Fluctuating  BP, tiredness, dizziness, diarrhea, and stiffness of throat.
Phone call from patient's mother this morning. States child had seizure at 1:00 am 10/24/09. Reports took child to ER, seizure lasted 30min, had 104 F temp upon arrival at ER. 11/2/2009 hospital records for 10/24/2009.Dx febrile seizure  Patient with seizure-like activity, febrile. Temp 104.2 upon admission. Tx: IV Ativan, IV ABX, IVF.  O2 at 2l. Admit for 23 hr obs.    ICD-9 code 780.31   11/03/09 Medical records receoved for DOS 10/24/09. Final DX: First febrile seizure, Purulent rhinitis Pateint awoke with seizure s/p immunizations same day, Tonic Posturing, head turned to the side, twitching head, 30 minutes total. fever 104.2. O2 sat 90%. Incrased on O2. Lab work essentially WNL. Flu neg. URI SX. Admitted per mother's request.   Additional ICD Codes: 472.0
First dose Moderna COVID-19 vaccine administered on 1/4/2021. Vaccinator did not schedule patient's second dose (unknown why this occurred, as scheduling 2nd dose is standard practice). The patient was subsequently scheduled by a non-clinical individual on 2/4 for an appointment 2/4 with note "Second Dose Pfizer." Pfizer was administered for 2nd dose on 2/4.
Information has been received from a 25 year old female certified medical assistant with a history of chickenpox at 5 years of age and no allergies who on 31-MAY-2007 administered a dose of Zostavax (lot # 657558/0461U). Concomitant therapy included prenatal vitamins (unspecified). While withdrawing the vaccine from the vial, it sprayed into her eyes and face. At the time of exposure, the reporter was 15 weeks pregnant. She wiped her face down with alcohol and flushed her eyes with water. Two hours later, she reported feeling fine. Unspecified medical attention was sought and no diagnostic laboratory tests were performed. A product quality complaint was not involved. Vaccine sprayed into eyes and face was considered to be an other important medical event by the reporter. Additional information has been requested.
not received 2nd dose yet; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 03 November 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not received 2nd dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 25-OCT-2023 and 31-OCT-2023 The patient reported that he/she would like to start the two shot regimen for Shingrix. However the pharmacy said that patient received the first dose back on November 03, 2019. The patient stated that he/she disputed this since his/her insurance at the time had no record of the Zoster immunization, and it did not show up on the state vaccine data base. The patient did remember receiving a flu shot that day and specifically refusing the Shingrix vaccine due to the expense and waiting for new insurance coverage the following year. In fact the clerk handed back the patient's paperwork and supposedly canceled that shot. They do have a record of patinet's flu vaccine that day. The patient questioned can he/she safely start the Shingrix inoculations four years later with dose 1 and then dose 2 or was there a lab test to be verified if te patient had the antibodies still around and the patient should only receive one Shingrix vaccine. The patient's primary care physician said he/she should be ok to start the series as if he/she had or had not received the vaccine back on November 03, 2019. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
weakness; dizziness; Fever of 101; fever (100.6); did not feel well; discomfort in her vaginal area, tense in muscles; discomfort in her vaginal area, tense in muscles; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well), VULVOVAGINAL DISCOMFORT (discomfort in her vaginal area, tense in muscles), MUSCLE TIGHTNESS (discomfort in her vaginal area, tense in muscles), ASTHENIA (weakness) and DIZZINESS (dizziness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20P or 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MALAISE (did not feel well), VULVOVAGINAL DISCOMFORT (discomfort in her vaginal area, tense in muscles) and MUSCLE TIGHTNESS (discomfort in her vaginal area, tense in muscles). On 23-Feb-2021, the patient experienced PYREXIA (fever (100.6)). On 24-Feb-2021, the patient experienced PYREXIA (Fever of 101). On an unknown date, the patient experienced ASTHENIA (weakness) and DIZZINESS (dizziness). At the time of the report, MALAISE (did not feel well), VULVOVAGINAL DISCOMFORT (discomfort in her vaginal area, tense in muscles), MUSCLE TIGHTNESS (discomfort in her vaginal area, tense in muscles), ASTHENIA (weakness), DIZZINESS (dizziness), PYREXIA (fever (100.6)) and PYREXIA (Fever of 101) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 100.6f 100.6F. On 24-Feb-2021, Body temperature: 101f 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
face went numb as well as her tongue and hands; face went numb as well as her tongue and hands; This is a spontaneous report from a contactable consumer (patient's mother). This consumer reported similar events for two patients. This is one for two reports.  A 18-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient's mother reported that her daughter had the same vaccine, and had the same exact reaction (face went numb as well as her tongue and hands) but received it at the hospital. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021541836 Same reporter/ drug/ event for different patients